On World Mental Health Day 2021, IIPDW Chairperson, Professor John Read wrote: This World Mental Health Day (October 10), nearly 8 million adults in England (17 percent of the adult population) will be on prescribed antidepressants. Sadly, none of them will receive any specialised help from the National Health Service (NHS) with the withdrawal symptoms that more than half of …
Recently for the Mad in America podcast, James Moore was in discussion with Professor Jim van Os and Doctor Peter Groot about their recent research on tapering strips, published in Therapeutic Advances in Psychopharmacology. Jim van Os is Professor of Psychiatric Epidemiology and Public Mental Health at Utrecht University Medical Centre, the Netherlands and Peter …
Friday 13th August at 5pm BST, 12PM EDT, 9AM PDT Mad in America, the Council for Evidence- based Psychiatry, the International Institute for Psychiatric Drug Withdrawal and A Disorder 4 Everyone are pleased to announce a series of live, online town hall discussions focussing on issues related to psychiatric drug withdrawal. Each town hall will …
A new article in the journal Psychosis examines whether everyone with a psychotic condition needs long-term antipsychotic treatment and evidence for alternative models of care. The article recommends that healthcare providers should be encouraged to develop a psychosocial treatment package for people with psychosis or schizophrenia that provides a realistic possibility of minimising antipsychotic exposure. …
The RADAR Study team are hosting an online webinar on Wednesday 9th June, 2-3:30pm BST, exploring lived experience perspectives on attempting to distinguish withdrawal effects from relapse, when reducing antipsychotics. Although there is increasing awareness of the difficulties in coming off psychiatric drugs, with antidepressants receiving attention in research and services, the effects of coming …
The Winter 2020 issue of the Journal of Critical Psychology, Counselling and Psychotherapy (JCPCP, 20,4), edited by Peter Lehmann, is a special issue on Withdrawal from Prescribed Psychotropic Drugs. It features articles on Medically unexplained symptoms and Functional neurological disorders Minimum dosage and monitoring of neuroleptics Recovering compensation for psychiatric withdrawal harm through litigation Internationally known authors …
Professor John Read, Chairperson of the Board of the International Institute for Psychiatric Drug Withdrawal has sent an open letter to Paul Chrisp, Director of the Centre for Guidelines, National Institute for Health and Care Excellence (NICE) in the UK. To: Paul Chrisp – Director, Centre for Guidelines, National Institute for Health and Care Excellence …
A new paper published in Schizophrenia Bulletin by Mark Horowitz, Sameer Jauhar, Sridhar Natesan, Robin Murray and David Taylor shows how extremely slow tapering off antipsychotics over months or years could reduce the potential negative experiences associated with antipsychotic withdrawal. The paper has been described as a ‘historic breakthrough’ in a recent article in the …
The International Institute of Psychiatric Drug Withdrawal has received a microgrant from Open Excellence to support us to continue our work. The grant will support us to design and deliver a training on psychiatric drug withdrawal in collaboration with clinicians, researchers and people with lived experience. It will also allow the Institute to support people …
A new article published in Therapeutic Advances in Psychopharmacology provides a clear and accessible summary of what Adele Framer has learned from helping thousands of patients taper their antidepressants and other psychotropic medications, in her role as founder and operator of the online peer-support forum SurvivingAntidepressants.org. Although psychiatric drug withdrawal syndromes have been recognised since the …